Erin McEvoy

This month’s webinar covered recent studies on cannabis use during pregnancy, CBD and anxiety, cannabis tea, and more.

The hemp products were seized from the ABC licensed locations for being out compliance with the state's new regulations.

Several surveys from 2024 reveal data and characteristics of adult American cannabis usage and opinions.

On November 5, 2024, Floridians will decide on Amendment 3, which proposes legalizing recreational cannabis. Former President Trump has stated support for this measure, aligning with his stance on state-level cannabis policies.

Listen to a Noid Factoid from Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC.

This interview discusses the challenges in conducting unbiased research on the benefits of minor cannabinoids for pets, the potential synergistic effects of terpenes, and emerging research on using cannabinoid blends to treat conditions like epilepsy in dogs.

This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.

The new hemp regulations, limiting THC levels in products, took effect in September.

Our sister publication, Nutritional Outlook, covered the current regulatory landscape for hemp as a supplement and how the 2024 Farm Bill could change things in the near future.

MM411’s president and co-founder, Chris DeVol, discusses challenges and trends in global cannabis education, plus upcoming initiatives of the company.

MM411’s president and co-founder, Chris DeVol, discusses the evolution of the company, their most popular cannabis education courses, and their partnership with Cannabis Science and Technology.

The ruling states that federal law does not block the ban on certain cannabinoid products in the state.

Researchers shared their latest research on the fungus that is a threat to seeds and crops across the nation.

This report is the first one published since the state’s legal market began.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

In this interview, we discuss the potential of cannabinoids in treating common health conditions in pets.

The studies highlight how changes in environment can alter cannabis during drying and curing.

In preparation for the outdoor cannabis harvest, this episode provided guidance on ensuring a successful production process.

Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic pain and potential benefits.

The study surveyed cannabis patients across the country on their use and perceptions of cannabis use during cancer treatment.

A ruling is expected this week regarding the lawsuit challenging the validity of signatures collected for two medical cannabis measures.

Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.

The study found improvement in symptom relief with participants who used the suppositories, compared to the treatment-as-usual group.

The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.

A leader in cannabis education in New Jersey, Stockton University offers a wide variety of courses to prepare its students to not only succeed in an ever-growing industry, but to also understand its complex history and shape its evolving future. Started six years ago, its Cannabis Studies Program continues its commitment to providing innovative and practical instruction to its students. Two influential figures in this space are Robert Mejia, Teaching Specialist in the Cannabis Studies Program, and Angela Speakman, Instructor in the Cannabis Studies Program. Here, they highlight the program’s practical approach to cannabis education, celebrate the success stories of graduates, discuss the National Cannabis Curriculum Convening, and address challenges in cannabis education and its role in the future.

Listen to a Noid Factoid from Jini Glaros, Chief Scientific Officer at Modern Canna Labs.

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

Several participants reported symptom relief and reduced reliance on pain medication.

A recently published white paper delves into data on market and consumer trends for pre rolls.

As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.